Metallothionein and Apoptosis during Differentiation of Myoblasts to Myotubes: Protection against Free Radical Toxicity
- 1 September 1999
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 159 (3), 175-184
- https://doi.org/10.1006/taap.1999.8755
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Induction of astrocyte metallothioneins (MTs) by zinc confers resistance against the acute cytotoxic effects of methylmercury on cell swelling, Na+ uptake, and K+ releaseBrain Research, 1998
- p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damageThe FASEB Journal, 1997
- Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitroChemico-Biological Interactions, 1995
- Two zinc‐dependent steps during G1 to S phase transitionJournal of Cellular Physiology, 1993
- In situ end‐labelling detects DNA strand breaks in apoptosis and other physiological and pathological statesThe Journal of Pathology, 1993
- Heterogeneity of antibodies to metallothionein isomers and development of a simple enzyme‐linked immunosorbent assayJournal of Biochemical Toxicology, 1992
- Quantification of metallothionein isoforms using an enzyme-linked immunosorbent assay (ELISA) with two specific antiseraToxicology and Applied Pharmacology, 1992
- The protein Id: A negative regulator of helix-loop-helix DNA binding proteinsCell, 1990
- A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts.The EMBO Journal, 1989
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976